股票 › ACHV
阿奇夫生命科学 ACHV
美股市值排名 #3472
$6.72 +$0.35 (+5.41%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $6.65 -1.04%
开盘$6.55
昨收$6.38
当日区间$6.25 – $6.75
成交量1.08M
市值$692.85M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$18.39M-46.4% YoY
净利润-$74.77M-487.9% YoY
摊薄每股收益-$0.80-116.2% YoY
自由现金流-$10.96M-20.9% YoY
经营现金流-$10.78M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-845.0%
资产收益率-91.5%
投入资本回报率-446.2%
流动比率0.95
负债/资产比率107.7%
现金及投资$187.30M
总负债$14.91M
净现金（净负债）$172.39M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $18.39M | $10.46M | $54.88M | $14.73M | $14.69M |
| 销售及管理费用 | $14.58M | $7.17M | $31.88M | $10.86M | $9.37M |
| -管理费用 | $14.58M | $7.17M | $31.88M | $10.86M | $9.37M |
| 研发费用 | $3.81M | $3.29M | $23.00M | $3.87M | $5.32M |
| 营业利润 | -$18.39M | -$10.46M | -$54.88M | -$14.73M | -$14.69M |
| 非经营性利息净收入（支出） | -$7.60M | $23,000.00 | $676,000.00 | $176,000.00 | $362,000.00 |
| 非经营性利息收入 | $1.48M | $297,000.00 | $1.50M | $427,000.00 | $554,000.00 |
| 非经营性利息支出 | $277,000.00 | $274,000.00 | $819,000.00 | $251,000.00 | $192,000.00 |
| 其他财务成本合计 | $8.80M | – | – | – | – |
| 其他收入（支出） | -$48.78M | $272,000.00 | -$444,000.00 | -$107,000.00 | -$111,000.00 |
| 证券出售收益 | -$48.67M | – | – | – | – |
| 特殊收益（费用） | -$100,000.00 | $285,000.00 | -$408,000.00 | -$114,000.00 | -$106,000.00 |
| -减：重组及并购费用 | $100,000.00 | -$285,000.00 | $408,000.00 | $114,000.00 | $106,000.00 |
| 其他非经营性收入（支出） | -$5,000.00 | -$13,000.00 | -$36,000.00 | $7,000.00 | -$5,000.00 |
| 税前利润 | -$74.77M | -$10.17M | -$54.65M | -$14.66M | -$14.44M |
| 净利润 | -$74.77M | -$10.17M | -$54.65M | -$14.66M | -$14.44M |
| 持续经营利润 | -$74.77M | -$10.17M | -$54.65M | -$14.66M | -$14.44M |
| 归属母公司净利润 | -$74.77M | -$10.17M | -$54.65M | -$14.66M | -$14.44M |
| 归属普通股股东净利润 | -$74.77M | -$10.17M | -$54.65M | -$14.66M | -$14.44M |
| 基本每股收益 | -$0.80 | -$0.19 | -$1.25 | -$0.28 | -$0.28 |
| 摊薄每股收益 | -$0.80 | -$0.19 | -$1.25 | -$0.28 | -$0.28 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $190.44M | $33.11M | $41.79M | $41.79M | $52.04M |
| 流动资产合计 | $188.29M | $31.06M | $39.89M | $39.89M | $50.06M |
| 现金及现金等价物与短期投资 | $187.30M | $29.27M | $36.38M | $36.38M | $48.11M |
| -现金及现金等价物 | $47.96M | $28.08M | $20.91M | $20.91M | $31.93M |
| -短期投资 | $139.35M | $1.19M | $15.48M | $15.48M | $16.18M |
| 其他流动资产 | $991,000.00 | $1.79M | $3.49M | $3.49M | $1.94M |
| 非流动资产合计 | $2.14M | $2.04M | $1.90M | $1.90M | $1.99M |
| 固定资产净值 | $34,000.00 | $49,000.00 | $64,000.00 | $64,000.00 | $79,000.00 |
| -固定资产原值 | $34,000.00 | $49,000.00 | $64,000.00 | $64,000.00 | $79,000.00 |
| 商誉及其他无形资产 | $1.84M | $1.73M | $1.79M | $1.79M | $1.84M |
| -商誉 | $1.03M | $1.03M | $1.03M | $1.03M | $1.03M |
| -其他无形资产 | $808,000.00 | $696,000.00 | $751,000.00 | $751,000.00 | $807,000.00 |
| 其他非流动资产 | $268,000.00 | $265,000.00 | $52,000.00 | $52,000.00 | $65,000.00 |
| 负债合计 | $205.12M | $22.43M | $20.27M | $20.27M | $18.43M |
| 流动负债合计 | $197.66M | $11.83M | $9.08M | $9.08M | $9.73M |
| 应付款 | $606,000.00 | $833,000.00 | $867,000.00 | $867,000.00 | $1.94M |
| -应付账款 | $606,000.00 | $833,000.00 | $867,000.00 | $867,000.00 | $1.94M |
| -一年内应付关联方款项 | $0.00 | – | – | – | – |
| 一年内应计费用 | $1.87M | $3.19M | $972,000.00 | $972,000.00 | $2.65M |
| 短期债务及融资租赁负债 | $7.49M | $5.63M | $3.77M | $3.77M | $1.26M |
| -一年内到期债务 | $7.45M | $5.58M | $3.70M | $3.70M | $1.20M |
| -一年内到期融资租赁负债 | $36,000.00 | $51,000.00 | $61,000.00 | $61,000.00 | $59,000.00 |
| 其他流动负债 | $184.75M | – | $1.56M | $1.56M | $1.44M |
| 非流动负债合计 | $7.46M | $10.59M | $11.19M | $11.19M | $8.70M |
| 长期债务及融资租赁负债 | $7.46M | $9.32M | $11.19M | $11.19M | $8.70M |
| -长期债务 | $7.46M | $9.32M | $11.19M | $11.19M | $8.67M |
| -长期融资租赁负债 | $0.00 | $0.00 | $5,000.00 | $5,000.00 | $21,000.00 |
| 股东权益合计 | -$14.68M | $10.68M | $21.52M | $21.52M | $33.62M |
| 股东权益 | -$14.68M | $10.68M | $21.52M | $21.52M | $33.62M |
| 股本 | $170,000.00 | $121,000.00 | $121,000.00 | $121,000.00 | $121,000.00 |
| -普通股 | $170,000.00 | $121,000.00 | $121,000.00 | $121,000.00 | $121,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $330.41M | $280.95M | $281.61M | $281.61M | $279.05M |
| 留存收益 | -$345.16M | -$270.39M | -$260.23M | -$260.23M | -$245.56M |
| 不影响留存收益的损益 | -$88,000.00 | $2,000.00 | $10,000.00 | $10,000.00 | $9,000.00 |
| 其他非流动负债 | – | $1.27M | – | – | – |
| 受限现金 | – | – | $20,000.00 | $20,000.00 | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$10.78M | -$6.93M | -$49.47M | -$17.98M | -$11.33M |
| 持续经营经营活动现金流净额 | -$10.78M | -$6.93M | -$49.47M | -$17.98M | -$11.33M |
| 持续经营净利润 | -$74.77M | -$10.17M | -$54.65M | -$14.66M | -$14.44M |
| 折旧、折耗与摊销 | $58,000.00 | $57,000.00 | $228,000.00 | $57,000.00 | $54,000.00 |
| 其他非现金项目 | -$563,000.00 | -$273,000.00 | $460,000.00 | $125,000.00 | $119,000.00 |
| 营运资金变动 | $71,000.00 | $4.14M | -$4.27M | -$4.80M | $597,000.00 |
| -预付资产变动 | $861,000.00 | $1.69M | -$1.40M | -$1.53M | -$456,000.00 |
| -应付账款及应计费用变动 | -$790,000.00 | $2.44M | -$2.87M | -$3.27M | $1.05M |
| -其他流动负债变动 | $0.00 | $0.00 | $0.00 | $1,000.00 | -$1,000.00 |
| 投资活动现金流净额 | -$137.80M | $14.28M | $6.11M | $709,000.00 | -$12.65M |
| 持续经营投资活动现金流净额 | -$137.80M | $14.28M | $6.11M | $709,000.00 | -$12.65M |
| 投资购置及出售净额 | -$137.62M | $14.28M | $6.12M | $713,000.00 | -$12.65M |
| 筹资活动现金流 | $168.46M | $21,000.00 | $51.53M | $6.26M | $4.04M |
| 持续经营筹资活动现金流净额 | $168.46M | $21,000.00 | $51.53M | $6.26M | $4.04M |
| 股票期权行使所得 | $215,000.00 | $21,000.00 | $1.39M | $1.27M | $120,000.00 |
| 期末现金余额 | $48.19M | $28.31M | $20.95M | $20.95M | $31.95M |
| 现金净变动 | $19.88M | $7.37M | $8.17M | -$11.01M | -$19.94M |
| 期初现金余额 | $28.31M | $20.95M | $12.77M | $31.95M | $51.89M |
| 汇率变动影响 | $3,000.00 | -$1,000.00 | $3,000.00 | $4,000.00 | -$1,000.00 |
| 自由现金流 | -$10.96M | -$6.93M | -$49.47M | -$17.98M | -$11.33M |
| -应收款变动 | – | – | $0.00 | $0.00 | – |
| 固定资产购置及出售净额 | – | – | -$4,000.00 | – | – |
| 债务发行及偿还净额 | – | – | $5.00M | $5.00M | – |
| 普通股发行净额 | – | – | $45.14M | -$2,000.00 | $3.92M |
暂无评论——快来第一个聊聊 ACHV。
登录后参与讨论。